Research and Markets, Ltd.

Egypt Pharmaceuticals and Healthcare Report - Q1 2010

Published in Law and Health Weekly, January 16th, 2010

Research and Markets has announced the addition of the "Egypt Pharmaceuticals and Healthcare Report Q1 2010" report to their offering.

In the Q110 Business Environment Ratings table for the 17 countries in the Middle East and Africa (MEA) region, Egypt has retained 9th position in the matrix above Morocco and Iran, but below Jordan and Oman. Key drawbacks of the Egyptian pharmaceuticals and healthcare market include low per-capita spending on drugs, as well as poor drug pricing and reimbursement conditions. Public sector health expenditure reached a value of EGP19.2bn (US$3.5bn) in 2008, accounting...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly

Source: Law and Health Weekly (2010-01-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry